Filing Details

Accession Number:
0001493152-23-031708
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-05 18:43:17
Reporting Period:
2023-08-31
Accepted Time:
2023-09-05 18:43:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1873835 Immix Biopharma Inc. IMMX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631486 Magda Marquet C/O Immix Biopharma, Inc.
11400 West Olympic Blvd., Suite 200
Los Angeles CA 90064
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-31 1,000 $2.01 1,000 No 4 P Indirect Via ALMA Life Sciences, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Via ALMA Life Sciences, LLC